Nanoveu Limited has signed distribution agreements for the it's antiviral protection products with Sanyo Trading Company Limited (Sanyo Trading) for the Thai and Malaysian markets. Through the agreements, Sanyo will look to leverage its extensive contacts in the Asia-Pacific region and will look to distribute a number of Nanoveu's products to groups including hospitals, banks, schools and shopping malls. Nanoveu will ship its business to business (B2B) rolls of antiviral film ­ to be applied to an increasing number of surfaces in addition to its consumer-focused antiviral mobile phone cases and door handles.

Nanoveu's antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses. The technology has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes. The antiviral protection has also been validated against other bacteria and viruses including e.Coli, Influenza A (subtype H3N2), and coronavirus MHV-A59.